Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page footer’s software/version indicator is updated from Revision v3.5.2 to Revision v3.5.3, reflecting a maintenance or release update rather than a change to the trial record itself.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision history now includes v3.5.2 and removes v3.5.0.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the study history.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision v3.4.3 was added to the study record history and Revision v3.4.2 was removed.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded revision: v3.4.2 to the history and removed revision v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedThe new screenshot shows a revision label 'Revision: v3.4.1' while the old screenshot shows 'Revision: v3.4.0', reflecting a minor update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.